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Unbiased “omics” techniques, such as next generation RNA-sequencing, can provide
entirely novel insights into biological systems. However, cellular heterogeneity presents
a significant barrier to analysis and interpretation of these datasets. The neurons of
the dorsal root ganglia (DRG) are an important model for studies of neuronal injury,
regeneration and pain. The majority of investigators utilize a dissociated preparation of
whole ganglia when studying cellular and molecular function. We demonstrate that the
standard methods for producing these preparations gives a 10%-neuronal mixture of cells,
with the remainder of cells constituting satellite glia and other non-neuronal cell types.
Using a novel application of magnetic purification, we consistently obtain over 95% pure,
viable neurons from adult tissue, significantly enriched for small diameter nociceptors
expressing the voltage gated ion channel Nav1.8. Using genome-wide RNA-sequencing
we compare the currently used (10% neuronal) and pure (95% nociceptor) preparations
and find 920 genes enriched. This gives an unprecedented insight into the molecular
composition of small nociceptive neurons in the DRG, potentially altering the interpretation
of previous studies performed at the tissue level, and indicating a number of novel markers
of this widely-studied population of cells. We anticipate that the ease of use, affordability
and speed of this technique will see it become widely adopted, delivering a greatly
improved capacity to study the roles of nociceptors in health and disease.
Keywords: pain, nociceptors, nociception, somatosensation, dorsal root ganglion, RNA-sequencing, peripheral
nervous system, regeneration
INTRODUCTION
Cell sorting techniques combined with transcriptional or epige-
netic profiling provide a unique insight into how gene expression
is regulated across different cell types. While cell type-specific
profiling is now widely employed by researchers in the oncology
and immunology fields (Hu et al., 2005; Heng et al., 2008), most
researchers studying the nervous system continue to assess gene
expression at the whole tissue level.
This is despite the fact that neural tissues contain a wide
variety of different cell types such as epithelial cells, fibroblasts,
glia and macrophages, as well as molecularly and functionally
distinctive subsets of neurons. This heterogeneity significantly
limits the usefulness of transcriptomic and epigenetic data gen-
erated to date. While sorting techniques, including fluorescence-
activated cell sorting (FACS), have been applied to neural
tissue, these often require transgenic animals and large amounts
of cellular material in order to recover sufficient RNA, and
are often better suited to neonate than adult neural tissue
(Lobo et al., 2006).
In the peripheral nervous system, a commonly studied tissue is
dorsal root ganglion (DRG). The peripheral nerve cell bodies con-
tained in the DRG are important targets for investigators assessing
sensory function, injury, regeneration and pain. Chronic pain is
one of the leading causes of long term disability, estimated to
affect one in five adults (Breivik et al., 2013). More than one
in three patients suffering chronic pain report inadequate pain
relief (Breivik et al., 2013)—yet many promising preclinical drug
targets have not translated into effective treatments. One reason
for this is the relatively poor understanding of the fundamen-
tal physiology and pathophysiology of pain-sensing nerve fibers
(nociceptors, a subset of peripheral nerve cells) at the molecular
level (Eijkelkamp et al., 2012).
We present a novel application of magnetic cell sorting
(MACS) which generates a 95% pure nociceptor preparation
from adult mouse DRG. This MACS preparation is enriched for
small nociceptive neurons expressing the voltage gated sodium
channel Nav1.8. Comparison of gene expression in mixed disso-
ciated ganglion with the MACS purified nociceptor preparation
reveals the transcriptional signature of nociceptors.
MATERIALS AND METHODS
ANIMALS
Adult male C57Bl/6 mice weighing between 20 and 25 g were
used for all experiments (Harlan, Bicester, UK). Animals were
housed under standard conditions (12 h light/dark cycle, lights
on between 7:00 a.m. and 7:00 p.m., free access to lab chow and
water, groups of 4–8). All care of animals was in accordance with
the United Kingdom Animals Scientific Procedures Act (1986).
Nav1.8 TdTomato mice have been extensively characterized
elsewhere (Shields et al., 2012).
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TISSUE PREPARATION
Mice were euthanized with a terminal dose of pentobarbital
and decapitated. DRG were taken from all levels as previously
described (Malin et al., 2007). For experiments on intact gan-
glia, DRG were snap frozen using liquid nitrogen, before being
homogenized in Trizol (Invitrogen). For unsorted and MACS-
sorted preparations, DRG were washed in F12 medium followed
by incubation in dissociating enzymes (3 mg/mL dispase, 0.1%
collagenase and 200 U/ml DNAse, all from Roche) for 30min at
37◦C. Dissociation enzymes were then removed and replaced with
F12. Cells were triturated 5 times using a P1000 tip to disrupt the
tissue. Cells in suspension were retained, and fresh F12 was added
to the remaining undisrupted material. This process was repeated
5 times. Cells in suspension were filtered through a 40μm filter
and centrifuged for 5min at 150 G. For unsorted preparations,
cells were resuspended in Trizol at this point and snap frozen.
MACS-SORTING OF DISSOCIATED DORSAL ROOT GANGLIA
Dissociated DRG neurons were washed in Dulbeccos PBS then
resuspended in 120μl MACS buffer (Miltenyi autoMACS HBSS-
based washing solution with 0.5% bovine serum albumin).
30μl of biotinylated non-neuronal antibody cocktail was added
(Miltenyi MACS Neuron Isolation Kit) and cells incubated at
4◦C for 5min. After washing in MACS buffer, cells were resus-
pended in 120μl MACS buffer with 30μl anti-biotin microbeads
(Miltenyi MACS Neuron Isolation Kit) and incubated at 4◦C
for 10min. Cells were then run through a LD exclusion column
placed in a QuadroMACS separator (Miltenyi Biotech), which
retained all microbead-conjugated, non-neuronal cells so that
only neurons were eluted. For MACS-sorted preparations, eluted
pure neurons were then centrifuged, resuspended in Trizol and
snap frozen.
IMMUNOCYTOCHEMISTRY
For characterization, unsorted preparations were plated on
poly-L-lysine/laminin coated coverslips. Sorted cells were plated
on poly-L-lysine coverslips incubated with Matrigel (BD
Biosciences) diluted 1:10 in F12. After ∼18 h in vitro, cells were
fixed in 2% PFA at 37◦C for 10min. Cells were then blocked
in 10% Normal Donkey Serum in PBS with 0.2% Triton-X for
30min at room temperature, followed by a 30min RT incuba-
tion in primary antibody. Cells were washed in PBS and incu-
bated in secondary antibody at room temperature for 30min,
followed by further washing and coverslipping with Vectashield
mounting medium (Vector Labs). Primary antibodies used were:
mouse β-III tubulin (Promega, G712A), rabbit glutamine syn-
thetase (Abcam, ab498371), mouse CGRP (Abcam, ab81887).
Secondaries were all Alexa 488 or 546 (Life Technologies).
Fluorescence was visualized with fixed exposure times using a
Zeiss Axioplan 2 microscope and analyzed using ImageJ software
and Graphpad Prism. Positive cells were defined as cells with an
intensity >30% that of the mean top 10 most intense cells in the
image being analyzed.
FLOW CYTOMETRY OF DISSOCIATED NEURONAL PREPARATIONS
Cells were prepared for cytometry as described above, with two
variations. Cells were prepared in cytometry buffer instead of
medium (Hank’s Buffered Saline Solution with 1M HEPES and
0.5M EDTA). Cells were prepared from mice expressing GFP
in Advillin-positive cells, i.e., all DRG neurons (Advillin-GFP
mouse obtained from Gensat). The pan-nuclear marker DRAQ5
(Biostatus, UK) was then added at 1:10,000. Unsorted and MACS
sorted samples were analyzed using an LSR Fortessa. The num-
ber of GFP-positive events were quantified as a percentage of all
DRAQ5-positive events to assay the proportion of neuronal to
non-neuronal cells.
RNA EXTRACTION AND LIBRARY PREPARATION FOR SEQUENCING
RNA was extracted from intact, unsorted and MACS-sorted sam-
ples using the RNeasy micro kit (Qiagen). Each sample (each n)
comprisedmaterial from 1, 2 or 8mice in the intact, unsorted and
MACS-sorted groups, respectively. RNA integrity was assessed on
an Agilent2100 Bioanalyzer (Agilent, Santa Clara, CA) and the
RNA integrity number of each sample was >8. PolyA-selected
RNA was used for complimentary DNA library preparation using
the NEBNext Ultra direction RNA Library Prep Kit according to
manufacturer’s instructions (NEB, Ipswich, MA). 100 bp reads
were sequenced on the Illumina HiSeq2000/2500 platform in
replicate flow cells.
DATA ANALYSES
Quality control, alignment and differential expression anal-
yses were performed on the Galaxy server (Giardine et al.,
2005; Blankenberg et al., 2010; Goecks et al., 2010). Cortical
neuron fastQ files were uploaded to Galaxy directly from
the European Nucleotide Archive (http://www.ebi.ac.uk/ena/
data/view/SRP033200, sample accessions SAMN02415125,
SAMN02415124). Briefly, fastQ files were uploaded, assessed for
sequencing quality using fastQC (http://www.bioinformatics.
babraham.ac.uk/projects/fastqc) and Picard Alignment
Summary Metrics (http://picard.sourceforge.net). Base calls
were of high quality across the full-length of the reads and
trimming was not required. FastQ files were aligned to the UCSC
mm10 build of the mouse genome using TopHat2 (Kim et al.,
2013), with the multiple alignment parameter (-g) set to two.
Aligned bam files from separate lanes were combined using the
Merge Bam tool from SamTools (Li et al., 2009), then fragments
per kilobase per million (FPKM) estimates were obtained using
Cufflinks version 2.1.1 (Trapnell et al., 2012). Genes were consid-
ered to be expressed if more than three samples within a group
had an FPKM value greater than 5.
Differential expression analyses were performed using CuffDiff
version 2.1.1 (Trapnell et al., 2012). Genes were considered
to be differentially expressed if they had a q < 0.05, log2-fold
change < −0.5 or >0.5, and mean FPKM > 5 in the group with
higher expression. Following differential expression analysis of
MACS sorted samples it became clear that these were contami-
nated with red blood cells (e.g., they had high levels of canonical
blood genes, such as Hbb-bs). To account for this, all genes
that were found to be both significantly upregulated in MACS
samples and had a median log2 RPKM > 3 in a recently pub-
lished mouse erythrocyte transcriptome study (An et al., 2014)
were removed prior to subsequent analysis (totaling 308 blood
genes).
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Principal component analysis, density and scatter plots were
created using the cummeRbund package in R (version 3.1.0).
Hierarchical clustering and heat maps were generated using
MultiExperiment Viewer (MeV) (Saeed et al., 2003). DAVID (Da
Wei Huang and Lempicki, 2008; Huang et al., 2009), Panther (Mi
et al., 2013), and STRING (Jensen et al., 2009) were used for gene
functional annotation and network analyses.
Datasets are available via GEO accession number GSE62424.
RESULTS
MACS-SORTED PURE NEURONAL PREPARATIONS ARE ENRICHED FOR
NOCICEPTORS
We used a novel application of magnetic cell sorting (MACS) to
obtain a 95% pure peripheral nerve cell body preparation from
adult DRG. Quantification of traditionally prepared, unsorted
dissociated DRG cultures stained for the neuronal marker β-III
Tubulin, the satellite glial cell marker glutamine synthetase (GS)
and the nuclear marker DAPI demonstrate that neuronal cells
constitute a mean of 9% of adherent, nucleated cells present
in these preparations one day after dissociation (Figures 1A,C).
In contrast, a DRG preparation subjected to MACS contains
more than 95% neuronal nuclei (Figures 1B,C). Cell size dis-
tribution indicates that magnetic sorting generates a prepa-
ration enriched for cells < 30μm in diameter (nociceptors)
(Figure 1D).
Flow cytometry analysis of acutely dissociated DRG prepara-
tions confirms that neurons constitute 9.8% of nucleated events
in the acute preparation (Supplementary Figure 1). This indicates
that the relatively large proportion of non-neuronal cells detected
after 1 day in culture do not simply reflect proliferating cells,
but is an accurate reflection of the cellular makeup of the acute
preparation. Note that while we observed that neurons only con-
stituted∼10% of cells in acutely dissociated preparations of DRG,
this is likely an underestimate of the total proportion of neurons
in the intact DRG as the dissociation process will cause some cells,
such as larger DRG neurons, to lyse.
We next performed MACS sorting on dissociated DRG
from transgenic animals carrying the TdTomato reporter in
cells expressing the voltage-gated sodium channel, Nav1.8
(Figures 1E,F). This confirmed that the MACS sorting process
generates a cell preparation enriched for nociceptors. In agree-
ment with previous studies (Shields et al., 2012), Nav1.8+ cells
make up only 76% of dissociated unsorted neurons, yet constitute
95% of the MACS sorted preparation (Figure 1G).
The proportion of cells expressing the neuropeptide calci-
tonin gene-related peptide (CGRP), which defined a subset of
nociceptors, is similar in unsorted (Figure 1H, 38%) and sorted
preparations (Figure 1I, 36%), indicating that the MACS sorting
process enriches cells according to size but introduces no bias in
neurochemical subtype (Figure 1J).
RNA-SEQUENCING OF INTACT, DISSOCIATED AND MACS-SORTED
PREPARATIONS IDENTIFIES THE NOCICEPTOR TRANSCRIPTOME
We next extracted high-quality RNA from either whole, intact
DRG, acutely dissociated, unsorted DRG or MACS-sorted
DRG for use in RNA-sequencing (study design illustrated in
schematic Figure 2A). The sequencing data was used to identify
unbiased gene expression profiles across the entire transcriptome.
Sequencing was performed on polyA+ messenger RNA of four
biological replicates for each condition at a depth of ∼18 million
reads per sample. Sequencing data were subject to quality con-
trol analyses prior to alignment with TopHat2. A high-confidence
transcriptome was generated using Cufflinks in Galaxy, and dif-
ferences in gene expression levels were analyzed using CuffDiff.
Only annotated genes were analyzed.
We initially determined how many genes were expressed in all
three conditions. We detected 7987 genes in intact DRG, 7929
genes in dissociated, unsorted samples and 7309 genes in MACS-
sorted samples, corresponding to ∼30% of known murine genes
(Figure 2B). The vast majority of these genes (6876, 81%) were
expressed in all three groups (Figure 2C).
Cell-type enrichment analysis performed using the CTen plat-
form (Shoemaker et al., 2012) accurately identified the overlap-
ping genes as DRG and other neuronal cell types (Figure 2D). In
contrast, genes found only in the intact and dissociated groups
were not identified as neuronal, confirming the ability of the
MACS sorting process to exclude non-neuronal cells.
Principal component analysis (PCA) was performed on all
genes. Intact DRG and dissociated, unsorted samples clustered
closely together, while MACS-sorted samples clustered separately
(Figure 2E). Pairwise comparison of replicates within each group
revealed a high degree of correlation (r2 = 0.81–0.87), indicating
the reproducibility of the preparation methods.
THE MACS-SORTED CELL TRANSCRIPTOME IDENTIFIES NOVEL
NOCICEPTOR-ENRICHED ION CHANNEL GENES
Nociceptor genes were identified by comparingMACS-sorted and
unsorted DRG preparations using the CuffDiff algorithm. A total
of 2392 differentially expressed genes were discovered, of which
920 (38.5%) were enriched in theMACS-sorted samples and 1473
(61.5%) were depleted (Figure 3A).
Consistent with the in vitro characterization, genes enriched
in the MACS-sorted samples include many known small neu-
ronal markers such as GDNF responsive receptor tyrosine kinase,
Ret (log2-fold change = 0.79, q = 0.0002) and neurofilament
peripherin (Prph log2-fold change = 0.39, q = 0.011). Depleted
genes include the large neuronal marker parvalbumin (log2-fold
change = −3.34, q = 0.0002) and the glial cell glutamate trans-
porter GLAST-1 (Slc1a3, log2-fold change = −6.99, q = 0.0044).
The genes enriched in MACS-sorted neurons represent all genes
expressed more abundantly in nociceptors than in other DRG
neurons and non-neuronal cells. To determine whether these
genes may also be nociceptor-specific, we performed an in silico
analysis of MACS transcriptional data against global gene expres-
sion data from pure cortical neurons (Zhang et al., 2014). 6140
genes were found to be differentially expressed between the two
datasets, of which 3190 (52%) were enriched in cortical neu-
rons and 2950 (48%) were enriched in nociceptors (described in
Supplementary Figure 2 and Supplementary Table 2). Of the 920
genes most enriched in the MACS-sorted preparation compared
to unsorted DRG, 548 (68%) were also significantly enriched
compared to cortical neurons. This suggests that these genes are
not only nociceptor-enriched, but may in fact be nociceptor-
specific.
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FIGURE 1 | Characterisation of MACS-sorted DRG neuronal preparation.
(A,B) Immunohistochemistry visualizing neuronal (β-III tubulin), satellite glial
(glutamine synthetase) or other non-neuronal (DAPI) cells in unsorted and
MACS-sorted neuronal preparations. (C) Quantification of neuronal, glial and
other non-neuronal cells shows that MACS-sorting generates >95% pure
neuronal preparation (n = 8 per condition). (D) Cell size distribution of neuronal
cells in unsorted and MACS-sorted preparations shows that the MACS-sorted
preparation is enriched for small cells <30 μm in diameter (n = 8 per
condition. ∗∗ = unpaired t-test p < 0.01). (E,F) Immunohistochemistry of
unsorted and MACS-sorted preparations generated from Nav1.8 TdTomato
reporter mice. (G) Percentage of cells positive for Nav1.8 is significantly
greater following MACS sorting (n = 4 per condition, Fisher’s exact test,
∗p < 0.05). (H,I) Immunohistochemistry visualizing the neuropeptide
calcitonin gene related peptide (CGRP) in unsorted and MACS-sorted
preparations. (J) The percentage of cells expressing CGRP is unchanged in
MACS-sorted preparations (n = 4, Fisher’s exact test p = 0.229).
Table 1 below shows highlighted results. All MACS vs. DRG
values are accessible in Supplementary Table 1 and MACS vs.
Cortical Neurons may be found in Supplementary Table 2.
Functional annotation clustering using DAVID indicates that
genes enriched in MACS-sorted preparations possess GO terms
related to ion channel activity and ion binding (false discov-
ery rate corrected p-value range 6.55e-4–2.8e-7; Supplementary
Table 3), and 43 genes related to ion channel activity were identi-
fied for downstream analysis (Figure 3B).
Jamieson et al. (2014) have recently described the pain
interactome, a pain-specific protein-protein interaction network
(Jamieson et al., 2014). Using the key nodes of the pain inter-
actome alongside the 43 ion channel activity genes in an unbi-
ased network analysis we discovered two major gene clusters
(Figure 3C). The largest cluster contained the known pain-
related genes from the pain interactome as well as various tran-
sient receptor potential channel members, purinoreceptors and
voltage-gated sodium channel subunits, the majority of which
have known functions in somatosensation or nociception. The
second cluster primarily contained calcium and potassium chan-
nel subunits, including the calcium channel subunit Cacna2d1
(alpha-2-delta-1) which is the major target of the neuropathic
pain drug, gabapentin (Bauer et al., 2009). The remaining ion
channel activity-related genes did not form clusters as they had
no known interactions with either the pain-related genes or the
calcium and potassium channel subunits, therefore represent-
ing a novel subset of nociceptor-enriched ion channel genes, the
majority of which have not been previously linked to pain.
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FIGURE 2 | Next-generation sequencing of intact, unsorted and
MACS-sorted DRG neuronal preparations. (A) Schematic illustrating
study design for sequencing. Four replicate samples were sequenced in
each group. (B) Graphs illustrate the distribution of FPKM values for all
genes in each experimental group. Similar distributions were obtained
for all groups, indicating that all groups have comparable coverage of
genes across a range of expression levels. Scatterplots compare
group-to-group log10 FPKM values. Divergence from the fit line indicates
dissimilar gene expression patterns. (C) Venn diagram illustrating
detection of 7987 genes in intact DRG, 7929 genes in unsorted
samples, and 7309 genes in MACS-sorted samples. The vast majority of
genes (6876, 81%) were expressed in all three groups. (D) Cell-type
enrichment analysis suggests that genes common to all three groups
are indicative of DRG and other neuronal cell types (filled line), while
genes found only in the intact and dissociated groups were
non-neuronal and most closely resembled osteoblast and brown adipose
tissue (hollow line). (E) Principal component analysis (PCA) performed on
all genes. Intact DRG and dissociated, unsorted samples cluster closely
together, while MACS-sorted samples cluster separately. Plotted values
are -log10 Bonferroni-corrected p-values.
DIFFERENTIAL SPLICING OF THE TrkB RECEPTOR IN NEURONS AND
NON-NEURONAL CELLS
One major advantage of RNA-Sequencing over microarrays is
the ability to measure isoform-level differences between samples.
Using Cuffdiff we identified 2444 transcripts that were differ-
entially expressed between MACS-sorted samples and unsorted
DRG samples, of which 1473 were depleted and 971 were
enriched in nociceptors, as well as 99 genes with alternate
promoter use and 63 genes that were differentially spliced
(Supplementary Table 4). Interestingly, one of the genes that
was significantly differentially expressed at the transcript level
was the brain-derived nerve growth factor (BDNF) recep-
tor, Ntrk2 (TrkB). There are two isoforms of mouse Ntrk2:
one (NM_001025074) encodes the full-length receptor and the
other (NM_008745) encodes a truncated version. Although both
isoforms were depleted from MACS cultures, the truncated
form was downregulated to a much greater extent (log2-fold
change = −2.9, = −6.9, Figure 4) and the message was vir-
tually absent (mean FPKM = 0.23, s.e.m. = 0.12, Figure 4
and Supplementary Table 4). This was similar to what was
observed for known non-neuronal genes in the MACS-sorted
samples, for example the voltage gated potassium channel Kir4.1
(Kcnj10, FPKM = 0.15, Supplementary Table 1) and the gluta-
mate transporter GLAST-1 (Slc1a3 FPKM= 0.04, Supplementary
Table 1). This suggests that, in contrast to CNS tissues where
the truncated form is expressed in both neuronal and non-
neuronal cells, in DRG truncated TrkB is primarily expressed in
non-neuronal cells while neurons only express the full length
isoform.
Isoform-specific expression analyses were also performed
against cortical neurons. These results may be accessed in
Supplementary Table 5.
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FIGURE 3 | Differential expression profiling of unsorted and
MACS-sorted DRG cultures. (A) Cuffdiff was used for differential
expression testing between unsorted and MACS-sorted samples.
Individual points represent genes. Of 23,991 annotated genes, 10,724
(44.7%) were not tested due to their low expression levels. Of the
remaining genes, 7579 (31.6%) were not significantly differentially
expressed and 5688 (23.7%) were. Of these, 2443 (10.2% of total)
passed stringent fold change and expression criteria and were used for
downstream analysis. (B) Heat map of ion channel expression in intact
DRG, unsorted and MACS-sorted cultures. Genes are hierarchically
clustered using average linkage clustering and expression is normalized
by gene. Ion channels were identified by functional annotation enrichment
analysis of MACS genes as they were found to be the most enriched
gene class (GO term “ion channel activity,” p = 1.89E-10, FDR =
2.80E-07) (C) Network analysis of ion channel genes and pain-associated
genes. Pink nodes represent pain-associated genes from the pain
interactome (Jamieson et al., 2014); orange spots indicate genes with no
known pain association; thickness of the edge represents the confidence
of the interaction. Unbiased MCL clustering revealed two primary
sub-clusters of ion channel genes, the majority of which have been
previously studied in the context of pain. Many of the ion channels that
do not group into these clusters are novel targets in the context of pain.
MACS-SORTING IDENTIFIES NOVEL TRANSCRIPTION FACTORS
PRESENT IN NOCICEPTORS
Transcriptional regulation is an important mechanism for
chronic pain (Perkins et al., 2014). Functional annotation analysis
of nociceptor-enriched genes identified 70 genes associated
with nucleic acid binding and transcription factor activity (the
top 15 are presented in Table 2, below, with the full list in
Supplementary Figure 3). This list includes Tlx3 and Pou4f1,
genes that are known to be critical for sensory neuron devel-
opment (Lopes et al., 2012; Zou et al., 2012) as well as 49
genes whose role in pain and somatosensation is not yet known.
Unbiased network analysis indicates that among these newly
identified nociceptor transcription factors, Klf5, Med10, Myc,
and Stat6 are predicted to interact with key nodes of the
pain interactome (Supplementary Figure 4; Jamieson et al.,
2014).
Importantly, comparison of intact DRG vs. dissociated DRG
samples indicated that only two of these genes were found to
be significantly induced after dissociation, though fold changes
were small (q < 0.05, Zfhx3 log2 fc = 0.39, Sox4 log2 fc = 0.45,
Supplementary Table 6). This implies that this list does not rep-
resent de novo induction of transcription factor expression as a
result of cell extraction and sorting, but rather reflects enrichment
in nociceptors.
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Table 1 | Genes with known roles in pain and somatosensation are
enriched in MACS-sorted nociceptors compared to unsorted DRG
(see also Supplementary Table 1).
































P2rx2 Purinoreceptor 2 3.36 4.95





Prph Peripherin 1.80 1189.14
Ret RET (GDNF receptor) 1.74 190.11
Scn10a Nav1.8 1.71 8010.07
Scn11a Nav1.9 2.14 3084.88
Scn9a Nav1.7 1.47 38.76





Trpa1 TRPA1 1.83 176.05
Trpv1 TRPV1 1.47 50.21
Trpv2 TRPV2 1.56 5.44
Many of these genes are also enriched in MACS-sorted nociceptors compared
to cortical neurons, indicating that these genes are not only nociceptor-enriched,
but may in fact be nociceptor-specific (see also Supplementary Figure 2 and
Table 2).
DISCUSSION
We present the first application of magnetic cell sorting (MACS)
to isolate and characterize nociceptor neurons from the adult
DRG using RNA-sequencing. We find that MACS increases the
purity of DRG sensory neuron cell body preparations from
<10% to >95%, a purity that cannot be obtained through any
other method. These MACS preparations are enriched for noci-
ceptor neurons <30μm in size expressing the voltage gated
sodium channel, Nav1.8. Comparison of RNA-sequencing data
in unsorted and nociceptor-enriched MACS-sorted preparations
enables genome-wide resolution of the nociceptor transcriptome.
We present novel biological insight into the ion channels, growth
factor receptor isoforms and transcription factors present in these
cells, and anticipate that both the novel sorting technique used
and the data generated will be of great utility to researchers study-
ing nociceptors in the context of pain, injury and regeneration.
The importance of attaining cell-type specificity in the con-
text of high-throughput transcriptomic technologies (most often
microarray and RNA-sequencing) is becoming increasingly clear
(as reviewed in Okaty et al., 2011a; Cruz et al., 2013). Data
generated from central nervous system (CNS) or peripheral ner-
vous system (PNS) tissue, given the high level of heterogeneity,
is subject to a number of limitations. The first is that any tran-
scriptional change occurring in small populations of cells is likely
to be underestimated if assessed in a composite tissue. Likewise,
genes regulated in opposite directions in neighboring cell types
will appear static in composite data. Similarly, transcripts which
are differentially spliced in different cell types cannot be dis-
tinguished. Furthermore, following experimental manipulations
such as injury, any change in the population of cells present in
the tissue (such as infiltration of immune cells) complicates the
attribution of any observed transcriptional change.
Obtaining cell-type specificity requires a means of identifying,
and a means of isolating cells of interest. A number of features
of adult neural tissue limit the applicability of the most com-
mon high throughput sorting technique, fluorescence-activated
cell sorting (FACS), in PNS. The sensitivity of adult neuronal cell
bodies to physical stress, the requirement for enzymatic disrup-
tion of tissue that may affect extracellular antibody epitopes, and
the relatively small number of cells available make it difficult to
recover sufficient RNA for high-throughput applications when
flow sorting PNS tissue.
Another sorting technique that is suitable for transcrip-
tome analysis of neural tissue is Translating Ribosome Affinity
Purification (TRAP)-Seq. TRAP requires a transgenic mouse with
a cell-type specific reporter allowing the labeling and isolation
of ribosome-associated RNA within the cells of interest. One
strength of the technique is that cell-type specific data can be
pulled down from a composite tissue without having to separate
constituent cell types. However, data generated using this tech-
nique does appear to be subject to a high degree of contamination
from other cell types (Okaty et al., 2011b). Furthermore, TRAP is
entirely dependent on the fidelity of the cell-type reporter used,
and, in contrast to RNA-sequencing of whole-cell lysate, cannot
detect non-coding RNA species.
Both FACS and TRAP require a transgenic reporter with high
fidelity for the cell type of interest, and are not applicable to
non-transgenic animals. In contrast, theMACS-sorting technique
can generate pure neuronal preparations from standard labo-
ratory animals with sufficient yield to carry out genome-wide
sequencing.
Aside from transcriptomic studies, MACS cultures will also
be extremely useful for in vitro study. Previously, preparing an
enriched preparation of DRG neurons required extended cul-
ture (> 1 week) in the presence of a mitotic inhibitor to deplete
contaminating non-neuronal cells (Lerch et al., 2012). This cul-
ture procedure is not widely used because of concerns about
off-target effects of mitotic inhibitors on neurons (Wallace and
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FIGURE 4 | RNA-Seq reveals differential expression of Ntrk2
isoforms in MACS-sorted cultures. Figure generated by the
Integrated Genome Browser using mapped reads from one
MACS-sorted (B) and one unsorted sample (A). Both Ntrk2 isoforms
are depleted from MACS-sorted cultures, though some message
remains. Interestingly, the junction between exons (16 and 17) is
not detected in the MACS-sorted cultures, implying that this isoform
is not expressed in nociceptors.
Table 2 | The most highly enriched genes with nucleic acid binding functions present in nociceptors.
Gene symbol Full gene name FPKM unsorted FPKM MACS log2-fold change
Bhlha9 Basic helix-loop-helix family member a9 5.45 26.06 2.26
Klf5 Krueppel-like factor 5 14.20 43.55 1.62
Ldb2 Lim domain binding 2 47.25 119.58 1.34
Sox11 SRY-box 11 2.30 5.55 1.27
Pou4f2 POU domain class 4 transcription factor 2/Brn3b 7.57 18.23 1.27
Pdlim1 PDZ and LIM domain protein 1 6.50 15.58 1.26
Zbtb48 Zinc finger and BTB containing 48 2.24 5.28 1.23
Atf5 Activating transcription factor 5 32.35 75.84 1.23
Isl2 Islet 2 81.72 190.99 1.22
Tlx3 T-cell leukemia homeobox 3 38.59 86.16 1.16
Myt1 Myelin transcription factor 1 15.02 33.49 1.16
Grhl3 Grainyhead-like 3 3.73 8.26 1.15
Casz1 Castor zinc-finger 1 14.45 31.99 1.15
Prdm12 PR domain containing 12 64.85 142.95 1.14
Aff2 AF4/FMR2 family member 2 2.92 6.42 1.13
Genes already known to have a role in these cells are highlighted in bold.
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Johnson, 1989), the likelihood that DRG neuron phenotype fol-
lowing prolonged culture will no longer resemble that of intact
DRG (Buschmann et al., 1998) and the low purity of the culture
it produces [74% neuronal (Lerch et al., 2012)]. For these rea-
sons, most investigators simply use mixed cultures when studying
DRG. However, for experiments focused on growth factor signal-
ing, where contaminating non-neuronal cells are sensitive to and
able to release growth factors, impurity of DRG culture is a sig-
nificant limitation (Kalous et al., 2012). The ability to generate
pure neuronal cultures will significantly simplify interpretation
of in vitro experiments using dissociated DRG neurons.
Our study design allowed us to identify nociceptor-enriched
genes by comparing global gene expression profiles of MACS-
sorted small DRG neurons and dissociated whole ganglia. Further
in silico analysis to compare nociceptor and cortical neuron tran-
scriptomes revealed that the majority of nociceptor-enriched
genes may also be PNS-specific, as these were found to be sig-
nificantly upregulated compared to cortical neurons. These genes
may therefore be useful drivers for nociceptor-specific Cre lines,
or for PNS-specific drug targeting. Further investigation of other
PNS neuronal subtypes, for example autonomic ganglia, would
help to refine this list.
One limitation of our study is that we cannot definitively
determine the source of genes that are expressed at lower lev-
els in nociceptors compared to the whole DRG. This is because
these transcripts could come from either large neurons or non-
neuronal cells. However, we observed that known non-neuronal
genes tend to have very low expression levels in MACS sorted
cultures (FPKM < 0.5). We used this heuristic to interpret the
alternate Ntrk2 isoform expression (Figure 4). Further work to
isolate and transcriptionally profile all of the cell types of the
DRG are required to verify the origin of depleted transcripts.
However, in the absence of this information, the list of depleted
genes may still be used to inform experiments. If researchers are
interested in a particular receptor due to pharmacological effi-
cacy, our differential expression data will help to identify whether
results may be due to a direct action on nociceptors (i.e. if the
receptor is enriched), or an indirect action (if the receptor is not
present).
Many of the ion channels we identify in nociceptors (includ-
ing Kcnab1, Scn2, and Kcnc2) have not previously been described
in the PNS. Given the attractiveness of therapeutics targeting ion
channels such as the sodium channel Nav1.7 (Eijkelkamp et al.,
2012; Lee et al., 2014), these channels could constitute novel tar-
gets for the treatment of pain or itch. One interesting feature
of the nociceptor transcriptome we observe is the relatively low
enrichment of TRPV1 (log2 FC = 0.59) in the MACS-sorted
preparation. This likely reflects the size-selection of the MACS
method, which will exclude TRPV1+ A-fibers. This results in a
relatively low enrichment for TRPV1 in the MACS-sorted prepa-
ration relative to unsorted DRG, as the latter contains these
TRPV1+ A-fibers (Mitchell et al., 2010).
The nociceptor-enriched transcription factors we describe
include a number with known roles in DRG morphogene-
sis and function. These include Tlx3 and Pou4f1, which con-
trol the development of subsets of nociceptors (Lopes et al.,
2012; Zou et al., 2012). Disrupting expression of nociceptor
development-controlling transcription factors can be incredi-
bly informative—for example, disruption of Runx1 reveals the
genes uniquely expressed in cutaneous and deep-tissue innervat-
ing nociceptors (Yang et al., 2013), while Runx3 can be used to
disrupt development of DRG proprioceptive neurons peripheral
and central axonal projections (Inoue et al., 2002; Levanon et al.,
2002).
Of the 70 genes with nucleic acid binding activity we iden-
tify in nociceptors, only 21 have a known function in DRG. Of
these 21 previously characterized genes, many control neurite
outgrowth and axonal regeneration following injury, including
Sox11, Pdlim1, Nfil3, Hivep3, and Smad1 (Jankowski et al., 2006;
Wu et al., 2006; Macgillavry et al., 2009; Ohno et al., 2009; Zou
et al., 2009). The remaining 49 uncharacterized genes include
Pou4f2 and Atf5, genes involved in the acute response to damage
and axon outgrowth in the optic nerve, another popular model
tissue for regeneration (Huang et al., 2014; Yasuda et al., 2014).
The finding of differential expression of the full length (FL)
and truncated (T1) isoforms of the BDNF receptor TrkB suggests
for the first time that only TrkB FL is present in nociceptors, with
TrkB T1 expressed in non-neuronal cells of the DRG (Schwann
cells or satellite glia). This advances previous studies in the
CNS, where TrkB T1 was found in glia, but both forms were
detected in neurons (Frisen et al., 1993; Armanini et al., 1995).
The nociceptor transcriptome we present allows investigators
to assess transcript-level differential expression for any gene of
interest.
In summary, the DRG nociceptor preparation produced by
MACS-sorting has many applications in vitro and in molecular
studies. We have demonstrated how the nociceptor transcrip-
tome, generated via RNA-sequencing of MACS-sorted DRG,
can be mined to gain novel biological insight. Knowledge
of the ion channels, splice isoforms and transcription factors
enriched in nociceptors will be of great utility to investiga-
tors studying this tissue in the context of pain, somatosensa-
tion and itch. As sequencing data in a wider array of other
tissues and cellular subtypes becomes available, it will deepen
our understanding of the defining features of the nociceptor
transcriptome.
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